Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Rheumatoid Arthritis: Emerging drug discovery targets' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Spinal Surgery | Oct 2011 | £2,845 | 100% |
| Arthritis - Pipeline Review Q3 2011 |
Jul 2011 | £315 | 96% |
| Therapeutic Monoclonal Antibodies Markets | Jun 2009 | £1,265 | 83% |
| IMS Global Biologics Perspectives | Oct 2009 | £5,800 | 75% |
| Protease Inhibitors Innovation Drives Drug Pipeline |
Feb 2009 | £2,370 | 73% |
| Personalized Medicine (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 72% |
| Top 10 Drug Delivery Technologies Market | Feb 2011 | £2,940 | 70% |
| Dynamic Antibody Industry | Aug 2005 | £2,760 | 68% |
| Angiongenesis Inhibitors and Stimulators | Feb 2011 | £3,130 | 64% |
| Monoclonal Antibody Based Products | Oct 2008 | £2,500 | 57% |
| Molecular Diagnostics (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,560 | 48% |
- Results 1 - 11 of 11
-
-
- 1
-
-
